Organon (OGN) Operating Income (2020 - 2026)
Organon (OGN) posted quarterly Operating Income of $323.0 million for Q2 2026, little changed year-over-year from $324.0 million in Q2 2025, and up 37.45% on a QoQ basis from $235.0 million in Q1 2026.
Organon (OGN) Operating Income (2020 - 2026) Analysis & Trends
Organon has reported Operating Income for 7 years, with the latest figure at $323.0 million in Q2 2026.
- Operating Income for Q2 2026 came in at $323.0 million, changed 0.31% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.1 billion (down 10.78% YoY), and the FY2025 annual result was $1.1 billion, down 22.27% from the prior year.
- Operating Income rose to $323.0 million in Q2 2026, from $235.0 million in the prior quarter.
- Over five years, Operating Income peaked at $411.0 million in Q3 2024 and troughed at -$579.0 million in Q4 2023.
- A 5-year average of -$37.2 million and a median of $45.5 million in 2022 frame the typical range for Operating Income.
- The widest annual swing landed in 2023, when Operating Income plunged 189.92%; it then surged 200.0% in 2024.
- A 5-year view of Operating Income shows it stood at -$483.0 million in 2022, then declined by 19.88% to -$579.0 million in 2023, then jumped by 149.74% to $288.0 million in 2024, then retreated by 27.08% to $210.0 million in 2025, then surged by 53.81% to $323.0 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were $323.0 million in Q2 2026, $235.0 million in Q1 2026, and $210.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 645.35 Mn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 323.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 323.00 Mn |
| Mar 31, 2026 | 235.00 Mn |
| Dec 31, 2025 | 210.00 Mn |
| Sep 30, 2025 | 358.00 Mn |
| Jun 30, 2025 | 324.00 Mn |
| Mar 31, 2025 | 239.00 Mn |
| Dec 31, 2024 | 288.00 Mn |
| Sep 30, 2024 | 411.00 Mn |
| Jun 30, 2024 | 386.00 Mn |
| Mar 31, 2024 | -429.00 Mn |
| Dec 31, 2023 | -579.00 Mn |
| Sep 30, 2023 | -532.00 Mn |
| Jun 30, 2023 | -386.00 Mn |
| Mar 31, 2023 | -345.00 Mn |
| Dec 31, 2022 | -483.00 Mn |
| Sep 30, 2022 | -269.00 Mn |
| Jun 30, 2022 | -301.00 Mn |
| Mar 31, 2022 | -119.00 Mn |
| Dec 31, 2021 | -363.00 Mn |
| Sep 30, 2021 | -220.00 Mn |